Dying of hematologic patients - Treatment characteristics in a German University Hospital

Supportive Care in Cancer

Volumn 20, Issue 11, 2012, Pages 2895-2902

  Brück, Patrick ^a,b   Pierzchlewska, Malgorzata ^b   Kaluzna Oleksy, Marta ^b   Lopez, Maria Elizabeth Ramos ^b   Rummel, Mathias ^a   Hoelzer, Dieter ^b,c   Böhme, Angelika ^b,c  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c Onkologikum Labor   (Germany)

Author keywords

Hematology; Palliative medicine; Treatment Characteristics

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; DISEASE CONTROL; DYING; FEMALE; GERMANY; HEMATOLOGIC MALIGNANCY; HISTIOCYTOMA; HOLISTIC CARE; HOME; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PAIN; PATIENT AUTONOMY; PATIENT CARE; PATIENT PREFERENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEDATION; SOLID TUMOR; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; BLOOD TRANSFUSION; FEMALE; GERMANY; HEMATOLOGIC NEOPLASMS; HOLISTIC HEALTH; HOSPITAL UNITS; HOSPITALS, UNIVERSITY; HUMANS; INFECTION; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PAIN MANAGEMENT; PALLIATIVE CARE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84868504433     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1417-8     Document Type: Article

References (33)

1. DeVita VT, Chu E (2008) A history of cancer chemotherapy. Cancer Res 68(21):8643-8653
2. McGrath P, Holewa H (2007) Special considerations for haematology patients in relation to end-of-life care: Australian findings. Eur J Cancer Care 16:164-171
3. Nightingale E (2000) Quality in palliative care. Aust Health Cons 3(2):39-40
4. Cella DF (1995) Measuring quality of life in palliative care. Semin Oncol 22(2 Suppl 3):73-81
5. Strasser F, Blum D, Bueche D (2010) Invasive palliative interventions: when are they worth it and when are they not? Cancer J 16 (5):483-487
6. Bookbinder M, McHugh ME (2010) Symptom management in palliative care and end of life care. Nurs Clin North Am 45 (3):271-327
7. Krug U, Röllig C, Koschmieder A, Heinecke A, Sauerland MC, Schaich M, Thiede C, Kramer M, Braess J, Spiekermann K, Haferlach T, Haferlach C, Koschmieder S, Rohde C, Serve H, Wörmann B, Hiddemann W, Ehninger G, Berdel WE, Büchner T, Müller-Tidow C, for the German Acute Myeloid Leukaemia Cooperative Group and the Study Alliance Leukemia Investigators (2010) Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes. Lancet 376:2000-2008
8. Niscola P, Tendas A, Scaramucci L, Giovaninni M, Cupelli L, De Sanctis V, Brunetti GA, Bondanini F, Palumbo R, Lamanda M, Battistini R, Cartoni C, Romani C, Arcuri E (2011) Pain in malignant hematology. Expert Rev Hematol 4(1):81-93
9. Hanks GW, de Conno F, Cherny N, Hanna M, Kalso E, McQuay HJ, Mercadante S, Meynadier J, Poulain P, Ripamonti C, Radbruch L, Roca I, Casas J, Sawe J, Twycross RG, Ventafridda V (2001) Morphine and alternative opioids in cancer pain: the EAPC recommendations. ExpertWorking Group of the Research Network of the European Association for Palliative Care. Br J Cancer 84 (5):587-593
10. Muller-Busch HC, Andres I, Jehser T (2003) Sedation in palliative care - a critical analysis of 7 years experience. BMC Palliat Care 2 (1):2
11. Sykes N, Thorns A (2003) Sedative use in the last week of life and the implications for end-of-life decision making. Arch Intern Med 163:341-344
12. Bauduer F, Capdupuy C, Renoux M (2000) Characteristics of deaths in a department of oncohaematology within a general hospital: a study of 81 cases. Supp Care Cancer 8:302-306
13. Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ (2008) Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol 26:3860-3866
14. Emanuel EJ, Young-Xu Y, Levinsky NG, Gazelle G, Saynina O, Ash AS (2003) Chemotherapy use among Medicare beneficiaries at the end of life. Ann Intern Med 138:639-643
15. Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC (2004) Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 22(2):315-321
16. Martoni AA, Tanneberger S, Mutri V (2007) Cancer chemotherapy near the end of life: the time has come to set guidelines for its appropriate use. Tumori 93(5):417-422
17. Koedoot CG, Oort FJ, de Haan RJ, Bakker PJ, de Graeff A, de Haes JC (2004) The content and amount of information given by medical oncologists when telling patients with advanced cancer what their treatment options are: palliative chemotherapy and watchful-waiting. Eur J Cancer 40(2):225-235
18. Sullivan AM, Lakoma MD, Matsuyama RK, Rosenblatt L, Arnold RM, Block SD (2007) Diagnosing and discussing imminent death in the hospital: a secondary analysis of physician interviews. J Palliat Med 10(4):882-893
19. Mackillop WJ, Stewart WE, Ginsburg AD, Stewart SS (1998) Cancer patients' perceptions of their disease and its treatment. Br J Cancer 58(3):355-358
20. Chow E, Andersson L, Wong R, Vachon M, Hruby G, Franssen E, Fung KW, Harth T, Pach B, Pope J, Connolly R, Schueller T, Stefaniuk K, Szumacher E, Hayter C, Finkelstein J, Danjoux C (2001) Patients with advanced cancer: a survey of the understanding of their illness and expectations from palliative radiotherapy for symptomatic metastases. Clin Oncol (R Coll Radiol) 13(3):204-208
21. Mack JW, Weeks JC, Wright AA, Block SD, Prigerson HG (2010) End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes for receipt of care consistent with preferences. J Clin Oncol 28(7):1203-1208
22. Hill QA (2010) Intensify, resuscitate or palliate: decision making in the critically ill patient with haematological malignancy. Blood Rev 24(1):17-25
23. Nosari A, Barberis M, Landonio G, Magnani P, Majno M, Oreste P, Sozzi P (1991) Infections in haematologic neoplasms: autopsy findings. Haematologica 76:135-140
24. Oneschuk D, Fainsinger R, Demoissac D (2002) Antibiotic use in the last week of life in three different palliative care settings. J Palliat Care 18(1):25-28
25. Reinbolt RE, Shenk AM, White PH, Navari RM (2005) Symptomatic treatment of infections in patients with advanced cancer receiving hospice care. J Pain Symptom Manag 30:175-182
26. White PH, Kuhlenschmidt HL, Vancura BG, Navari RM (2003) Antimicrobial use in patients with advanced cancer receiving hospice care. J Pain Symptom Manag 25(5):438-443
27. Dunn A, Carter J, Carter H (2003) Anemia at the end of life: prevalence, significance, and causes in patients receiving palliative care. J Pain Symptom Manag 26:1132-1139
28. Stalfelt AM, Brodin H, Pettersson S, Eklöf A (2003) The final phase in acute myeloid leukaemia (AML): a study on bleeding, infection and pain. Leuk Res 27:481-488
29. Wandt H, Ehninger G, Gallmeier WM (2001) New strategies for prophylactic platelet transfusion in patients with hematologic diseases. Oncologist 6:446-450
30. Bruera E, Belzile M,Watanabe S, Fainsinger RL (1996) Volume of hydration in terminal cancer patients. Supp Care Cancer 4:147-150
31. Oh DY, Kim JH, Lee SH, Kim DW, Im SA, Kim TZ, Heo DS, Bang YJ, Kim NK (2007) Artificial nutrition and hydration in terminal cancer patients: the real and the ideal. Supp Care Cancer 15:631-636
32. Higginson IJ, Sen-Gupta GJ (2000) Place of care in advanced cancer: a qualitative systematic literature review of patient preferences. J Palliat Med 3(3):287-300
33. Niscola P, de Fabritiis P, Cartoni C, Romani C, Sorrentino F, Dentamaro T, Piccioni D, Scaramucci L, Giovannini M, Amadori S, Mandelli F (2006) Home care management of patients affected by hematologic malignancies: a review. Haematologica 91(11):1523-1529